Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

In 2021 Professor Andrew Price was appointed Clinical Director of Trauma and Orthopaedics at the Oxford University Hospitals NHS Foundation Trust. After 9 months in post, we find out what the challenges are and what he’s been able to bring to the role.

Professor Andrew Price

You started a new role as Clinical Director of Trauma and Orthopaedics at the Oxford University Hospitals NHS Foundation Trust. What does that entail?

As the Clinical Director in the Trauma and Orthopaedics Directorate I look after the Nuffield Orthopaedics Centre, Orthopaedics and Rheumatology, trauma at the John Radcliffe Hospital, and trauma at the Horton Hospital. I've been doing it since last August and I'm responsible for the day to day running of the directorate, covering clinical care across patients, and staff.

For me, it's all about patient care, putting the patient at the front of it. But also looking after our staff and trying to create a happy working environment. I'm trying to follow the Trust's principles, but at the same time, trying to bring in some of the learning from my time as an academic in terms of innovation, and quality to try and keep moving forward.

What are some of the projects you have been working on?

I've been coordinating the recovery plan to try and get post COVID clinical care back up to normal, and then there's managing the backlog. These are two different things, and we're moving in the right direction.

Working closely with the University I'm helping to identify the musculoskeletal components for the next round of funding from the Biomedical Research Council.

I'm also trying to support digital transformation in the Trust in terms of working with EPR (the electronic patient record) for data collection which will help facilitate research. I'd also like to see an increased use of digital technology in theatre.

We are committed to the Trust and University's principles of improving diversity and equality in opportunities and access, so a part of my role is in supporting inclusivity.

Are you still doing research?

I continue to have academic time at the Botnar and am still heavily involved in research. I've recently secured a grant for a placebo trial to study a novel treatment for osteoarthritis of the knee.

How does your role support the strategy at the Botnar Institute?

I am working closely with Johnny Rees, Director of the Botnar in terms of trying to strengthen the link between the university and the hospital and integrate research from the Botnar into the clinical departments. One of our aims is to be able to recruit our patient population to studies to take the science forward, and then also to take the science and translate it into real care.

Similar stories

Emergency to use the FORCE pathway for wrist fractures in children

New research from the University of Oxford has shown that doctors can simplify treatment for the most common fracture in children, reducing NHS costs.

Kennedy researchers awarded funding to improve the understanding of inflammatory bowel diseases

A new £1.5M grant from the Medical Research Council (MRC) to the Powrie Group at the Kennedy Institute will help define different pathotypes of inflammatory bowel diseases that could lead to better and more focused treatments for patients.

Yoshi Itoh wins the International Dupuytren Award 2022

Yoshi Itoh, Associate Professor and Principal Investigator Cell Migration Group at the Kennedy Institute has been awarded the International Dupuytren Award 2022.

Taking a break from immune-suppressing medicines doubles the antibody response to COVID-19 booster vaccination

The Oxford Clinical Trials Research Unit (OCTRU) at NDORMS played a key role in the VROOM study which found that pausing immune-suppressing medicines such as methotrexate can increase the response to COVID-19 booster jabs.

Ten Years of Athena Swan in the Medical Sciences Division

2022 marks ten years since the first Athena Swan Bronze applications from the Medical Sciences Division. Ten years later, and all 16 departments in the Division have achieved a Silver Award. We look at NDORMS’ Athena Swan journey.

NDORMS researchers awarded Associate Professor title

The University of Oxford has awarded the title of Associate Professor to Adam Cribbs and Luke Jostins.